Home › Encyclopedia › GHRP-2: Research Status, Identity, and Trial Data
Research / Unapproved

GHRP-2: Research Status, Identity, and Trial Data

Molecular formulaC45H55N9O6
Molecular weight818 g/mol
Registered trials0
PubChem CID6918245

What GHRP-2 Is

GHRP-2 is a synthetic peptide compound with no FDA-approved label and no approved medical use. It has a molecular formula of C45H55N9O6 and a molecular weight of approximately 818 (PubChem CID 6918245). Because no regulatory label exists for this compound, there is no established indication, dosing standard, or confirmed mechanism of action to report.

Trial Footprint

Publicly registered clinical trial data show no listed trials for GHRP-2 at this time. There is currently no trial sample available to summarize in terms of design, phase, or status.

FAQ

Is GHRP-2 FDA approved?
No. GHRP-2 has no FDA-approved label, no approved brand name, and no approved medical indication. It is classified as an unapproved research compound.
What is GHRP-2 chemically?
GHRP-2 is a synthetic peptide with the molecular formula C45H55N9O6 and a molecular weight of about 818. It is catalogued in PubChem under CID 6918245.
Are there clinical trials studying GHRP-2?
Available registry data show no listed clinical trials for GHRP-2 at this time. This means there is no public trial phase, enrollment, or outcome data to reference.
What side effects are associated with GHRP-2?
No adverse event report data are currently available for GHRP-2, so no side effect pattern can be summarized from that source.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem

Updated 2026-09-26